BC Week In Review | Jul 20, 2015
Company News

amp biosimilars deal

amp granted an undisclosed Chinese pharmaceutical company exclusive, Chinese rights to ABY-018 . The humanized mAb is a biosimilar of an undisclosed cancer product. The undisclosed company will fund development after the preclinical testing and commercialization....
Items per page:
1 - 1 of 1